Tessera Therapeutics
Latest round
- Series C
Last raised
- Apr 2022
Total raised
- $632M
Investors
- 13
About Tessera Therapeutics
Based in the US, Tessera Therapeutics, Inc.Tessera Therapeutics, Inc. is focused on genome engineering, integrating therapeutic messages into the human genome.Tessera Therapeutics specializes in Gene Writing™, a transformative genome engineering technology designed to address the underlying causes of genetic diseases by directly integrating therapeutic messages into the genome. The company develops non-viral delivery systems for permanent, tissue-targeted genomic modifications, primarily targeting genetic disorders such as sickle cell disease and T-cell-related conditions.Tessera Therapeutics generates revenue through strategic partnerships and collaborations with healthcare organizations, research institutions, and pharmaceutical companies focused on genetic therapies. The company is focused on launching new genetic therapies and plans to expand into new markets in North America and Europe by 2025. The funds will be applied to accelerate the development and commercialization of their Gene Writing technologies, targeting significant health issues through innovative solutions.
Who invested in Tessera Therapeutics
13 investors across 2 rounds
See all investors in Tessera Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Tessera Therapeutics
Who invested in Tessera Therapeutics?
Tessera Therapeutics has 13 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tessera Therapeutics raised?
Tessera Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Tessera Therapeutics last raise money?
Tessera Therapeutics's most recent round on record is a Series C, in Apr 2022.
What does Tessera Therapeutics do?
Based in the US, Tessera Therapeutics, Inc.
Where is Tessera Therapeutics headquartered?
Tessera Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Tessera Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Tessera Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Tessera Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.